(Q34290034)
Statements
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis (English)
Eleftheria Mavridou
Roger J M Bruggemann
Johan W Mouton
23 August 2010
1 reference